Changes in molecular epidemiology and antimicrobial resistance profiles of Clostridioides (Clostridium) difficile strains in the United States between 2011 and 2017

Bartlett, 1980, Clinical and laboratory observations in Clostridium difficile colitis, Am. J. Clin. Nutr., 33, 2521, 10.1093/ajcn/33.11.2521 Kwon, 2015, The morbidity, mortality, and costs associated with Clostridium difficile infection, Infect. Dis. Clin. N. Am., 29, 123, 10.1016/j.idc.2014.11.003 Lessa, 2015, C.d.S.T. Emerging Infections Program. Burden of Clostridium difficile infection in the United States, N. Engl. J. Med., 372, 2369, 10.1056/NEJMoa1408913 Miller, 2011, Comparison of the burdens of hospital-onset, healthcare facility-associated Clostridium difficile Infection and of healthcare-associated infection due to methicillin-resistant Staphylococcus aureus in community hospitals, Infect. Control Hosp. Epidemiol., 32, 387, 10.1086/659156 Khanna, 2012, The epidemiology of community-acquired Clostridium difficile infection: a population-based study, Am. J. Gastroenterol., 107, 89, 10.1038/ajg.2011.398 Chitnis, 2013, Epidemiology of community-associated Clostridium difficile infection, 2009 through 2011, JAMA Intern Med, 173, 1359, 10.1001/jamainternmed.2013.7056 Bartlett, 2002, Clostridium difficile-associated enteric disease, Curr. Infect. Dis. Rep., 4, 477, 10.1007/s11908-002-0032-0 Kelly, 1994, Clostridium difficile colitis, N. Engl. J. Med., 330, 257, 10.1056/NEJM199401273300406 E.I.P. Centers for Disease Control and Prevention E.I.P. Centers for Disease Control and Prevention Jousimies-Somer, 2002 Clinical and Laboratory Standards Institute, 2018 Carman, 2012, In vivo selection of rifamycin-resistant Clostridium difficile during rifaximin therapy, Antimicrob. Agents Chemother., 56, 6019, 10.1128/AAC.00974-12 European Committee on Antimicrobial Susceptibility Testing, 2018 Stubbs, 1999, PCR targeted to the 16S-23S rRNA gene intergenic spacer region of Clostridium difficile and construction of a library consisting of 116 different PCR ribotypes, J. Clin. Microbiol., 37, 461, 10.1128/JCM.37.2.461-463.1999 Svenungsson, 2003, Epidemiology and molecular characterization of Clostridium difficile strains from patients with diarrhea: low disease incidence and evidence of limited cross-infection in a Swedish teaching hospital, J. Clin. Microbiol., 41, 4031, 10.1128/JCM.41.9.4031-4037.2003 Wilcox, 2012, Changing epidemiology of Clostridium difficile infection following the introduction of a national ribotyping-based surveillance scheme in England, Clin. Infect. Dis., 55, 1056, 10.1093/cid/cis614 Alvarez-Perez, 2017, Subtyping and antimicrobial susceptibility of Clostridium difficile PCR ribotype 078/126 isolates of human and animal origin, Vet. Microbiol., 199, 15, 10.1016/j.vetmic.2016.12.001 Freeman, 2015, Pan-European longitudinal surveillance of antibiotic resistance among prevalent Clostridium difficile ribotypes, Clin. Microbiol. Infect., 21, 248 e9, 10.1016/j.cmi.2014.09.017 Guh, 2017, Risk factors for community-associated Clostridium difficile infection in adults: a case-control study, Open Forum Infect Dis, 4, 10.1093/ofid/ofx171 Giancola, 2018, Prevalence of the Clostridium difficile BI/NAP1/027 strain across the United States Veterans Health administration, Clin. Microbiol. Infect., 24, 877, 10.1016/j.cmi.2017.11.011 Cheknis, 2018, 38 Katz, 2018, The evolving epidemiology of Clostridium difficile infection in Canadian hospitals during a postepidemic period (2009-2015), CMAJ (Can. Med. Assoc. J.), 190, E758, 10.1503/cmaj.180013 He, 2013, Emergence and global spread of epidemic healthcare-associated Clostridium difficile, Nat. Genet., 45, 109, 10.1038/ng.2478 Dingle, 2017, Effects of control interventions on Clostridium difficile infection in England: an observational study, Lancet Infect. Dis., 17, 411, 10.1016/S1473-3099(16)30514-X Freeman, 2018, The ClosER study: results from a three-year pan-European longitudinal surveillance of antibiotic resistance among prevalent Clostridium difficile ribotypes, 2011-2014, Clin. Microbiol. Infect., 24, 724, 10.1016/j.cmi.2017.10.008 Alam, 2017, Community environmental contamination of toxigenic Clostridium difficile, Open Forum Infect Dis, 4, 10.1093/ofid/ofx018 Wendt, 2014, Clostridium difficile infection among children across diverse US geographic locations, Pediatrics, 133, 651, 10.1542/peds.2013-3049 Kociolek, 2015, Molecular epidemiology of Clostridium difficile infections in children: a retrospective cohort study, Infect. Control Hosp. Epidemiol., 36, 445, 10.1017/ice.2014.89 Dharmasena, 2018, Isolation of toxigenic Clostridium difficile from animal manure and composts being used as biological soil amendments, Appl. Environ. Microbiol., 84, 10.1128/AEM.00738-18 Anderson, 2017, Identification of novel risk factors for community-acquired Clostridium difficile infection using spatial statistics and geographic information system analyses, PLoS One, 12, 10.1371/journal.pone.0176285 Huys, 2010, Intra- and interlaboratory performances of two commercial antimicrobial susceptibility testing methods for bifidobacteria and nonenterococcal lactic acid bacteria, Antimicrob. Agents Chemother., 54, 2567, 10.1128/AAC.00407-10 Mayrhofer, 2008, Comparison of broth microdilution, Etest, and agar disk diffusion methods for antimicrobial susceptibility testing of Lactobacillus acidophilus group members, Appl. Environ. Microbiol., 74, 3745, 10.1128/AEM.02849-07 Bolmstrom, 1993, Susceptibility testing of anaerobes with Etest, Clin. Infect. Dis., 16, S367, 10.1093/clinids/16.Supplement_4.S367 Miller, 2011, Divergent rifamycin susceptibilities of Clostridium difficile strains in Canada and Italy and predictive accuracy of rifampin Etest for rifamycin resistance, J. Clin. Microbiol., 49, 4319, 10.1128/JCM.05100-11 Dingle, 2019, A role for tetracycline selection in recent evolution of agriculture-associated Clostridium difficile PCR ribotype 078, mBio, 10, 10.1128/mBio.02790-18